Persistence of Leishmania parasites in scars after clinical cure of american cutaneous leishmaniasis: Is there a sterile cure?

Journal of Infectious Diseases

Volumn 189, Issue 6, 2004, Pages 1018-1023

  Mendonça, Mitzi G ^a   De Brito, Aria E F ^b   Rodrigues, Eduardo H G ^b   Bandeira, Valdir ^a   Jardim, Márcio L ^a   Abath, Frederico G C ^b,c  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Núcleo de Tele Saúde NUTES Hospital das Clínicas   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MEGLUMINE ANTIMONATE; PROTOZOAL DNA;

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LEISHMANIA; MALE; PARASITE CULTIVATION; PARASITE IDENTIFICATION; PARASITE ISOLATION; PERSISTENT INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTOZOON; SCAR; SKIN LEISHMANIASIS;

ADOLESCENT; ADULT; ANIMALS; CICATRIX; DNA, PROTOZOAN; FEMALE; HUMANS; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED;

EID: 1642378873     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/382135     Document Type: Article

References (33)

1. World Health Organization. Special Programme for Research and Training in Tropical Diseases. Leishmaniasis section. Available at: http://www.who.int/ tdr/index.html. Accessed 10 June 2003.
2. Grimaldi G, David JR, McMahon-Pratt D. Identification and distribution of New World Leishmania species characterized by serodem analysis using monoclonal antibodies. Am J Trop Med Hyg 1987; 36:270-87.
3. Saravia NG, Weigle K, Segura I, et al. Recurrent lesion in human Leishmania braziliensis infection - reactivation or reinfection? Lancet 1990; 336:398-402.
4. Belkaid Y, Hoffmann KF, Mendez S, et al. The role of interleukin IL-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med 2001; 194:1497-506.
5. Bogdan C, Donhauser N, Doring R, Rollighoff M, Diefenbach A, Rittig MG. Fibroblast as host cells in latent leishmaniasis. J Exp Med 2000; 191:2121-9.
6. Murray PJ. Defining the requirements for immunological control of mycobacterial infections. Trends Microbiol 1999; 7:366-72.
7. Bogdan C, Rollinghoff M. The immune response to Leishmania: mechanisms of parasite control and evasion. Int J Parasitol 1998; 28:121-34.
8. Aebischer T, Moody SF, Handman E. Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host. Infect Immun 1993; 61:220-6.
9. Rossel RA, Duran RJ, Rossel O, Rodriguez AM. Is leishmaniasis ever cured? Trans R Soc Trop Med Hyg 1992; 86:251-3.
10. Delgado O, Guevara P, Silva S, Belfort E, Ramirez JL. Follow-up of a human accidental infection by Leishmania (Viannia) braziliensis using conventional immunologic techniques and polymerase chain reaction. Am J Trop Med Hyg 1996; 55:267-72.
11. Schubach A, Haddad F, Oliveira-Neto MP, et al. Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients. J Infect Dis 1998; 178:911-4.
12. Schubach A, Marzochi MC, Cuzzi-Maya T, et al. Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure. Am J Trop Med Hyg 1998; 58:824-7.
13. le Fichoux Y, Quaranta JF, Aufeuvre JP, et al. Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in southern France. J Clin Microbiol 1999; 37:1953-7.
14. Morales MA, Cruz I, Rubio JM, et al. Relapses versus reinfections in patients coinfected with Leishmania infantum and human immunodeficiency virus type 1. J Infect Dis 2002; 185:1533-7.
15. de Bruijn MHL, Barker DC. Diagnosis of New World leishmaniasis: specific detection of species of the Leishmania braziliensis complex by amplification of kinetoplast DNA. Acta Trop 1992; 52:45-58.
16. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
17. Rodrigues EHG, Brito MEF, Mendonça MG, et al. Evaluation of PCR for diagnosis of American cutaneous leishmaniasis in an endemic area of Northeastern Brazil. J Clin Microbiol 2002; 40:3572-6.
18. Cupolillo E, Grimaldi J, Momem H. A general classification of New World Leishmania using numerical zymotaxonomy. Am J Trop Med Hyg 1994; 50:296-311.
19. Silveira FT, Ishikawa IAY, De Souza AAA, Lainson R. An outbreak of cutaneous leishmaniasis among soldiers in Belém, Pará State, Brazil, caused by Leishmania (Viannia) lindebergi n. sp.: a new leishmanial parasite of man in the Amazon region. Parasite 2002; 9:43-50.
20. Oliveira-Neto MP, Mattos M, Souza CSF, Fernandes O, Pirmez C. Leishmaniasis recidiva cutis in New World cutaneous leishmaniasis. Int J Dermatol 1998; 37:846-9.
21. Coutinho SG, Pirmez C, Da-Cruz AM. Parasitological and immunologica follow-up of American tegumentary leishmaniasis patients. Trans R Soc Trop Med Hyg 2002; 96(Suppl 1):S173-8.
22. Silva ES, Pacheco RS, Gontijo CMF, Carvalho IR, Brazil RP. Visceral leishmaniasis caused by Leishmania (Viannia) braziliensis in a patient infected with human immunodeficiency virus. Rev Inst Med Trop Sao Paulo 2002; 44:145-9.
23. Ramos-Santos C, Hernandez-Montes O, Sanchez-Tejeda G, Monroy-Ostria A. Visceral leishmaniosis caused by Leishmania (L.) mexicana in a Mexican patient with human immunodeficiency virus infection. Mem Inst Oswaldo Cruz 2000; 95:729-33.
24. Sampaio RNR, Salaro CP, Resende P, de Paula CDR. Leishmaniose tegumentar americana associada a AIDS: relato de quatro casos. Rev Soc Bras Med Trop 2002; 35:651-4.
25. Czechowicz RT, Millard TP, Smith HR, Ashton RE, Lucas SB, Hay RJ. Reactivation of cutaneous leishmaniasis after surgery. Br J Dermatol 1999; 141:1113-6.
26. Ferreira MS, Borges AS. Some aspects of protozoan infections in immunocompromised patients - a review. Mem Inst Oswaldo Cruz 2002; 97:443-57.
27. Brito MEF, Mendonça MG, Gomes YM, Jardim ML, Abath FGC. Dynamics of the antibody response in patients with therapeutic or spontaneous cure of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 2001; 95:203-6.
28. Guevara P, Ramirez JL, Rojas E, Scorza JV, Gonzalez N, Anez N. Leishmania braziliensis in blood 30 years after cure [letter]. Lancet 1993; 341:1341.
29. Aviles H, Belli A, Armijos R, Monroy FP, Harris E. PCR detection and identification of Leishmania parasites in clinical specimens in Ecuador: a comparison with classical diagnostic methods. J Parasitol 1999; 85:181-7.
30. Weigle KA, de Davalos M, Heredia P, Molineros R, Saravia NG, D'Alessandro A. Diagnosis of cutaneous and mucocutaneous leishmaniasis in Colombia: a comparison of seven methods. Am J Trop Med Hyg 1987; 36:489-96.
31. Nichols WW, Ledwith BJ, Manam SW, Troilo PJ. Potential DNA vaccine integration into host cell genome. Ann NY Acad Sci 1995; 772:30-9.
32. Rodriguez N, Bailey BN, Martin MM, Oldfield E, Urbina JA, Docampo R. Radical cure of experimental cutaneous leishmaniasis by the bisphosphonate pamidronate. J Infect Dis 2002; 186:138-40.
33. Botelho ACC, Tafuri WL, Genaro O, Mayrink W Histopathology of human American cutaneous leishmaniasis before and after treatment. Rev Soc Bras Med Trop 1998; 31:11-8.